ADMA Biologics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ADMA Biologics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 68% to $258,214,999. The net income raised on -$28,239,000 and profit margin reached -11%. Total operating expenses were $66,586,000.
Profit Margin
| 2014 | 5.91M | -16.81M | -284.22% |
|---|---|---|---|
| 2015 | 7.17M | -17.96M | -250.36% |
| 2016 | 10.66M | -19.51M | -183.05% |
| 2017 | 22.76M | -43.75M | -192.26% |
| 2018 | 16.98M | -65.74M | -387.06% |
| 2019 | 29.34M | -57.04M | -194.37% |
| 2020 | 42.21M | -87.60M | -207.5% |
| 2021 | 80.94M | -84.45M | -104.34% |
| 2022 | 154.07M | -85.18M | -55.29% |
| 2023 | 258.21M | -28.23M | -10.94% |
ADMA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 258.21M | 154.07M | 80.94M | 42.21M | 29.34M | 16.98M | 22.76M | 10.66M | 7.17M | 5.91M |
Cost of revenue | 169.27M | 118.81M | 79.76M | 61.29M | 39.50M | 42.19M | 29.16M | 6.36M | 4.31M | 3.74M |
Gross profit | 88.94M | 35.26M | 1.17M | -19.07M | -10.15M | -25.20M | -6.40M | 4.30M | 2.86M | 2.17M |
Operating exp. | ||||||||||
Research and development | 3.3M | 3.61M | 3.64M | 5.90M | 2.34M | 3.92M | 6.22M | 7.68M | 7.01M | 9.51M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 66.58M | 74.63M | 59.54M | 45.84M | 31.26M | 35.07M | 32.06M | 21.63M | 18.37M | 18.19M |
Operating income | 21.63M | -39.36M | -58.37M | -64.91M | -41.42M | -60.28M | -39.30M | -17.33M | -15.51M | -16.01M |
Other income (expenses), net | -49.87M | -26.53M | -13.27M | -10.83M | -6.85M | -127.12K | -4.44M | 4.49K | -2.45M | -1.34M |
Income before tax | -28.23M | -65.90M | -71.64M | -75.74M | -48.27M | -65.74M | -43.75M | -19.51M | -17.96M | -17.36M |
Income tax expense | 0 | 19.27M | 12.80M | 11.85M | 8.76M | 5.45M | 4.44M | 2.18M | 2.45M | -551.72K |
Net income | -28.23M | -85.18M | -84.45M | -87.60M | -57.04M | -65.74M | -43.75M | -19.51M | -17.96M | -16.81M |
Earnings per share | ||||||||||
Basic EPS | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 |
Diluted EPS | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |